Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The cellular activity of several regulatory and signal transduction proteins, which depend on the Hsp90 molecular chaperone for folding, is markedly decreased by geldanamycin and by radicicol (monorden). We now show that these unrelated compounds both bind to the N-terminal ATP/ADP-binding domain of Hsp90, with radicicol displaying nanomolar affinity, and both inhibit the inherent ATPase activity of Hsp90 which is essential for its function in vivo. Crystal structure determinations of Hsp90 N-terminal domain complexes with geldanamycin and radicicol identify key aspects of their nucleotide mimicry and suggest a rational basis for the design of novel antichaperone drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Self-citationDynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4829 · Cited by 735
Self-citationGrenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., Binart, N., Mester, J., & Baulieu, E.-E. (1984) · Nature · doi:10.1038/308850a0 · Cited by 434
Research works printed but not linked: 15
- Kwon H. J., 1992, Biosci. Biotechnol. Biochem., 56, 539
- Zhao J. F., 1995, Oncogene, 11, 173
- Kwon H. J., 1995, J. Biochem., 118, 228
- Fukazawa H., 1991, Biochem. Pharmacol., 42, 1671
- Smith D. F., 1995, Mol. Cell. Biol., 15, 6812
- Whitesell L., 1996, Endocrinology, 10, 712
- Ali J. A., 1993, Biochemistry, 32, 2724
- Cutler H. G., 1987, Agric. Biol. Chem., 51, 3338
- Schnur R. C., 1995, J. Med. Chem., 38, 3820
- Schnur R. C., 1995, J. Med. Chem., 38, 3812
- Hartmann F., 1997, Int. J. Cancer, 70, 229, 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l
- Dai K., 1996, J. Biol. Chem., 271, 22034
- Whitesell L., 1992, Cancer Res., 52, 1728
- Prodromou C., 1996, PROTEINS: Struct. Funct. Genet., 25, 522
- Merrit E. A., 1994, Acta Crystallogr., 50, 873
Cited by
Items 301–400 of 1,000
Ou, J., Ou, Z., Ackerman, A. W., Oldham, K. T., & Pritchard, K. A. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01299-6 · Cited by 63
Yoshino, T., Ng, F., & Danishefsky, S. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064270e · Cited by 62
A Concise Route to Benzofused Macrolactones via Ynolides: Cycloproparadicicol
Yang, Z., & Danishefsky, S. J. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036192q · Cited by 62
Pedersen, N. M., Madshus, I. H., Haslekås, C., & Stang, E. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0191 · Cited by 61
McEneaney, V., Harvey, B. J., & Thomas, W. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.043 · Cited by 61
The Heat Shock Protein 90-Targeting Drug Cisplatin Selectively Inhibits Steroid Receptor Activation
Rosenhagen, M. C., Sőti, C., Schmidt, U., Wochnik, G. M., Hartl, F. U., Holsboer, F., Young, J. C., & Rein, T. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0141 · Cited by 71
Hsp90/p50cdc37 Is Required for Mixed-lineage Kinase (MLK) 3 Signaling
Zhang, H., Wu, W., Du, Y., Santos, S. J., Conrad, S. E., Watson, J. T., Grammatikakis, N., & Gallo, K. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311377200 · Cited by 61
Wax, S. D., Piecyk, M., Maritim, B., & Anderson, P. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10780 · Cited by 61
Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors
Shevtsov, M. A., Multhoff, G., Mikhaylova, E. R., Shibata, A., Guzhova, I. V., & Margulis, B. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215284 · Cited by 60
Multifaceted roles of HEAT SHOCK PROTEIN 90 molecular chaperones in plant development
Tichá, T., Samakovli, D., Kuchařová, A., Vavrdová, T., & Šamaj, J. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa177 · Cited by 63
Wesche, J., Małecki, J., Więdłocha, A., Skjerpen, C. S., Claus, P., & Olsnes, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600477200 · Cited by 60
Regulation of the Src Family Kinase Lck by Hsp90 and Ubiquitination
Giannini, A. L. M., & Bijlmakers, M.-J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5667-5676.2004 · Cited by 67
Forrest, M. L., Zhao, A., Won, C.-Y., Malick, A. W., & Kwon, G. S. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.003 · Cited by 59
Contributions of Co-Chaperones and Post-Translational Modifications Towards Hsp90 Drug Sensitivity
Walton‐Diaz, A., Khan, S., Bourboulia, D., Trepel, J. B., Neckers, L., & Mollapour, M. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.88 · Cited by 63
Synthesis and biological evaluation of coumarin replacements of novobiocin as Hsp90 inhibitors
Kusuma, B. R., Khandelwal, A., Gu, W., Brown, D. R., Liu, W., Vielhauer, G. A., Holzbeierlein, J. M., & Blagg, B. S. J. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.056 · Cited by 59
Brassinosteroid nuclear signaling recruits HSP 90 activity
Samakovli, D., Margaritopoulou, T., Prassinos, C., Milioni, D., & Hatzopoulos, P. (2014) · New Phytologist · doi:10.1111/nph.12843 · Cited by 64
Wrona, I. E., Gozman, A., Taldone, T., Chiosis, G., & Panek, J. S. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo1000109 · Cited by 60
Fu, J., Chen, D., Zhao, B., Zhao, Z., Zhou, J., Xu, Y., Xin, Y., Liu, C., Luo, L., & Yin, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049194 · Cited by 62
Workman, P. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0593-0 · Cited by 59
Conformation–activity relationships of polyketide natural products
Larsen, E. M., Wilson, M. R., & Taylor, R. E. (2015) · Natural Product Reports · doi:10.1039/c5np00014a · Cited by 58
Park, J., Yeh, M. W., Wong, M. G., Lobo, M., Hyun, W. C., Duh, Q., & Clark, O. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020340 · Cited by 58
UCS15A, a non-kinase inhibitor of Src signal transduction
Sharma, S. V., Oneyama, C., Yamashita, Y., Nakano, H., Sugawara, K., Hamada, M., Kosaka, N., & Tamaoki, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204296 · Cited by 64
Prince, T. L., Kijima, T., Tatokoro, M., Lee, S., Tsutsumi, S., Yim, K. H., Rivas, C., Alarcon, S. V., Schwartz, H., Khamit-Kush, K. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141786 · Cited by 60
Chan, J. N. Y., Vuckovic, D., Sleno, L., Olsen, J. B., Pogoutse, O., Havugimana, P. C., Hewel, J. A., Bajaj, N., Wang, Y., Musteata, F. M., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016642 · Cited by 67
Trentin, L., Frasson, M., Donella‐Deana, A., Frezzato, F., Pagano, M. A., Tibaldi, E. V., Gattazzo, C., Zambello, R., Semenzato, G., & Brunati, A. M. (2008) · Blood · doi:10.1182/blood-2008-02-139139 · Cited by 62
ATP-Binding Site of Bacterial Enzymes as a Target for Antibacterial Drug Design
Škedelj, V., Tomašič, T., Mašič, L. P., & Zega, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101121s · Cited by 60
Lee, M.-G., Liu, Y., Lee, Y.-L., El‐Shazly, M., Lai, K.-H., Shih, S., Ke, S.-C., Hong, M., Du, Y.-C., Yang, J., et al. (2018) · Marine Drugs · doi:10.3390/md16060204 · Cited by 57
Cohen‐Saidon, C., Carmi-Levy, I., Keren, A., & Razin, E. (2005) · Blood · doi:10.1182/blood-2005-07-2648 · Cited by 57
Hughes, D., Guttenplan, J. B., Marcus, C. B., Subbaramaiah, K., & Dannenberg, A. J. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0149 · Cited by 57
RetractedWaters, B., Saxena, G., Wanggui, Y., KAU, D. A., Wrigley, S. K., Stokes, R. W., & DAVIES, J. E. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.407 · Cited by 56
Heat shock protein 90 inhibition: rationale and clinical potential
Den, R. B., & Lu, B. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012445574 · Cited by 56
Heat Shock Proteins In Cancer: Targeting the ‘Chaperones’
Nahleh, Z. A., Tfayli, A., Najm, A. A. A. M., Sayed, A. E., & Nahle, Z. A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.50 · Cited by 56
Heat shock proteins and cancer: How can nanomedicine be harnessed?
Sauvage, F., Messaoudi, S., Fattal, E., BARRATT, G. M., & Vergnaud, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.013 · Cited by 59
Structural Basis of the Radicicol Resistance Displayed by a Fungal Hsp90
Prodromou, C., Nuttall, J. M., Millson, S. H., Roe, S. M., Sim, T., Tan, D., Workman, P., Pearl, L. H., & Piper, P. W. (2009) · ACS Chemical Biology · doi:10.1021/cb9000316 · Cited by 60
Self-citationChrovian, C. C., Knapp‐Reed, B., & Montgomery, J. (2008) · Organic Letters · doi:10.1021/ol702961v · Cited by 56
Ibrahim, S. R. M., Mohamed, S. G. A., Altyar, A. E., & Mohamed, G. A. (2021) · Current Microbiology · doi:10.1007/s00284-021-02533-6 · Cited by 55
Hsp90: From Cellular to Organismal Proteostasis
Somogyvári, M., Khatatneh, S., & Sőti, C. (2022) · Cells · doi:10.3390/cells11162479 · Cited by 58
Hombach, A., Ommen, G., Chrobak, M., & Clos, J. (2012) · Cellular Microbiology · doi:10.1111/cmi.12057 · Cited by 57
Mechanistic Studies on Hsp90 Inhibition by Ansamycin Derivatives
Onuoha, S. C., Mukund, S. R., Coulstock, E. T., Sengerová, B., Shaw, J. S., McLaughlin, S. H., & Jackson, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.065 · Cited by 58
Nardo, D. D., Masendycz, P. J., Ho, S., Cross, M., Fleetwood, A. J., Reynolds, E. C., Hamilton, J. A., & Scholz, G. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409745200 · Cited by 55
Ligand Interactions in the Adenosine Nucleotide-binding Domain of the Hsp90 Chaperone, GRP94
Wassenberg, J. J., Reed, R. C., & Nicchitta, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001476200 · Cited by 57
Heat Shock Protein 90: A Unique Chemotherapeutic Target
Cullinan, S. B., & Whitesell, L. J. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.001 · Cited by 62
Xiong, M. P., Yáñez, J. A., Remsberg, C. M., Ohgami, Y., Kwon, G. S., Davies, N. M., & Forrest, M. L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.015 · Cited by 54
Anticancer fungal natural products: Mechanisms of action and biosynthesis
Yuan, S., Gopal, J. V., Ren, S., Chen, L., Liu, L., & Gao, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112502 · Cited by 58
Geldanamycin decreases Raf‐1 and Akt levels and induces apoptosis in neuroblastomas
Kim, S., Kang, J., Hu, W., Evers, B. M., & Chung, D. H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10820 · Cited by 54
Natural Product Inhibitors of Hsp90: Potential Leads for Drug Discovery
Amolins, M. W., & Blagg, B. S. J. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787316056 · Cited by 57
Blind cavefish and heat shock protein chaperones: a novel role for hsp90alpha in lens apoptosis
Hooven, T. A., Yamamoto, Y., & Jeffery, W. R. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041874th · Cited by 54
Dernovšek, J., & Tomašič, T. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108396 · Cited by 58
Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges
Piper, P. W., & Millson, S. H. (2011) · Pharmaceuticals · doi:10.3390/ph4111400 · Cited by 58
Self-citationMonovalent cation dependence and preference of GHKL ATPases and kinases1
Hu, X., Machius, M., & Yang, W. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00519-2 · Cited by 53
Multiple Poliovirus Proteins Repress Cytoplasmic RNA Granules
Dougherty, J. D., Tsai, W.-C., & Lloyd, R. E. (2015) · Viruses · doi:10.3390/v7122922 · Cited by 53
5-Aryl-4-(5-substituted-2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone
Čikotienė, I., Kazlauskas, E., Matulienė, J., Michailovienė, V., Torresan, J., Jachno, J., & Matulis, D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.003 · Cited by 53
Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion
Xie, Q. R., Gao, C.-F., Shinomiya, N., Sausville, E. A., Hay, R. V., Gustafson, M. F., Shen, Y., Wenkert, D., & Woude, G. F. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208499 · Cited by 54
Piper, P. W., Panaretou, B., Millson, S. H., Trumana, A., Mollapour, M., Pearl, L. H., & Prodromou, C. (2003) · Gene · doi:10.1016/s0378-1119(02)01102-2 · Cited by 58
Self-citationHsp90: Still a viable target in prostate cancer
Centenera, M. M., Fitzpatrick, A. K., Tilley, W. D., & Butler, L. M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.005 · Cited by 53
Alternative Approaches to Hsp90 Modulation for the Treatment of Cancer
Hall, J. A., Forsberg, L. K., & Blagg, B. S. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.89 · Cited by 54
Austin, C., Pettit, S. N., Magnolo, S. K., Sanvoisin, J., Chen, W., Wood, S. P., Freeman, L. D., Pengelly, R. J., & Hughes, D. E. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112445785 · Cited by 52
Zhou, V. W., Han, S., Brinker, A., Klock, H. E., Caldwell, J. S., & Gu, X.-J. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.04.011 · Cited by 52
Kim, T.-H., Keum, G., & Pae, A. N. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.780597 · Cited by 51
Design, synthesis, and evaluation of small molecule Hsp90 probes
Taldone, T., Zatorska, D., Patel, P. D., Zong, H., Rodina, A., Ahn, J. H., Moulick, K., Guzmán, M. L., & Chiosis, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.013 · Cited by 53
A “Double-Edged” Scaffold: Antitumor Power within the Antibacterial Quinolone
Bisacchi, G. S., & Hale, M. R. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666151223095839 · Cited by 58
Synthesis of novel fluorescent probes for the molecular chaperone Hsp90
Llauger, L., Felts, S. J., Huezo, H., Rosen, N. X., & Chiosis, G. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.065 · Cited by 57
The Hsp90 Chaperone Complex Regulates GDI-dependent Rab Recycling
Chen, C. Y., & Balch, W. E. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-12-1096 · Cited by 50
Griffin, T., Valdez, T. V., & Mestril, R. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00921.2003 · Cited by 51
AIP gene and familial isolated pituitary adenomas
Ozfirat, Z., & Korbonits, M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.001 · Cited by 56
Structural and functional studies of Leishmania braziliensis Hsp90
da Silva, K. P., Seraphim, T. V., & Borges, J. C. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.004 · Cited by 53
Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90
Tago, K., Tsukahara, F., Naruse, M., Yoshioka, T., & Takano, K. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.057 · Cited by 59
Davies, N. G. M., Browne, H. L., Davis, B. J., Drysdale, M. J., Foloppe, N., Geoffrey, S., Gibbons, B., Hart, T. W., Hubbard, R. E., Jensen, M. R., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.08.050 · Cited by 54
Wicklow, D. T., Jordan, A. M., & Gloer, J. B. (2009) · Mycological Research · doi:10.1016/j.mycres.2009.10.001 · Cited by 49
Recent Advances in Cancer Therapeutics
Chessum, N. E. A., Jones, K., Pasqua, E., & Tucker, M. (2015) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2014.11.002 · Cited by 53
Association between Hsp90 and the ClC-2 chloride channel upregulates channel function
Hinzpeter, A., Lipecka, J., Brouillard, F., Baudouin-Legros, M., Dadlez, M., Edelman, A., & Fritsch, J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00209.2005 · Cited by 57
A novel class of Hsp90 inhibitors isolated by structure-based virtual screening
Park, H., Kim, Y., & Hahn, J. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.069 · Cited by 51
Gougèlet, A., Bouclier, C., Marsaud, V., Maillard, S., Mueller, S. O., Korach, K. S., & Renoir, J. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.018 · Cited by 62
Castorena, K. M., Weeks, S. A., Stapleford, K. A., Cadwallader, A. M., & Miller, D. J. (2007) · Journal of Virology · doi:10.1128/jvi.00189-07 · Cited by 52
Xiong, M. P., Yáñez, J. A., Kwon, G. S., Davies, N. M., & Forrest, M. L. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21509 · Cited by 48
Huggins, D. J., & Tidor, B. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzr036 · Cited by 53
Heat shock proteins: the fountainhead of innate and adaptive immune responses
Basu, S., & Srivastava, P. K. (2000) · Cell Stress and Chaperones · doi:10.1379/1466-1268(2000)005<0328:tghaad>2.0.co;2 · Cited by 133
Bayih, A. G., Folefoc, A., Mohon, A. N., Eagon, S., Anderson, M. O., & Pillai, D. R. (2016) · Malaria Journal · doi:10.1186/s12936-016-1625-7 · Cited by 47
High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer
Zhang, S., Guo, S., Li, Z., Li, D., & Zhan, Q. (2019) · PeerJ · doi:10.7717/peerj.7946 · Cited by 48
HSP90α and HSP90β Isoforms Selectively Modulate MHC Class II Antigen Presentation in B Cells
Houlihan, J. L., Metzler, J., & Blum, J. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804296 · Cited by 49
Resorcylic acid lactones: A pluripotent scaffold with therapeutic potential
Barluenga, S., Dakas, P., Boulifa, M., Moulin, É., & Winssinger, N. (2008) · Comptes Rendus Chimie · doi:10.1016/j.crci.2008.01.020 · Cited by 48
Wang, T., Mäser, P., & Picard, D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00591 · Cited by 47
Chakraborty, A., Mohapatra, S. S., Barik, S., Roy, I., Gupta, B., & Biswas, A. (2023) · Bioscience Reports · doi:10.1042/bsr20220324 · Cited by 53
Stebbing, J., Gazzard, B., Portsmouth, S., Gotch, F. M., Kim, L. U., Bower, M., Mandalia, S., Binder, R. J., Srivastava, P. K., & Patterson, S. (2003) · Blood · doi:10.1182/blood-2003-03-0891 · Cited by 46
Yan, L., Cerny, R. L., & Cirillo, J. D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.3.567-578.2004 · Cited by 49
Kasza, Á., Hunya, Á. G., Frank, Z., Fülöp, F., Török, Z., Balogh, G. E., Sántha, M., Bálind, Á., Bernáth, S., Blundell, K. L. I. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150860 · Cited by 46
Self-citationJana, N. K., & Nanda, S. (2018) · New Journal of Chemistry · doi:10.1039/c8nj02534g · Cited by 46
Zininga, T., & Shonhai, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235930 · Cited by 49
Schmollinger, S., Schulz‐Raffelt, M., Strenkert, D., Veyel, D., Vallon, O., & Schroda, M. (2013) · Molecular Plant · doi:10.1093/mp/sst086 · Cited by 48
Macrocyclic Inhibitors of Hsp90
Johnson, V. A., Singh, E. K., Nazarova, L. A., Alexander, L. D., & McAlpine, S. R. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610792232088 · Cited by 46
Inhibitors of HSP90 and other chaperones for the treatment of cancer
Dymock, B. W., Drysdale, M. J., McDonald, E., & Workman, P. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.6.837 · Cited by 46
Jiménez, M. F. T., Ghaffari, N., Buiate, E. A. S., Moore, N., Schwartz, S., Johnson, C. D., & Vaillancourt, L. J. (2016) · BMC Genomics · doi:10.1186/s12864-016-2546-0 · Cited by 49
Phillips, J. J., Yao, Z., Zhang, W., McLaughlin, S. H., Laue, E. D., Robinson, C. V., & Jackson, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.059 · Cited by 53
Powell, E., Wang, Y., Shapiro, D. J., & Xu, W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.104356 · Cited by 45
Impaired NO signaling in small pulmonary arteries of chronically hypoxic newborn piglets
Fike, C. D., Aschner, J. L., Zhang, Y., & Kaplowitz, M. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00345.2003 · Cited by 45
Adenosine Nucleotides and the Regulation of GRP94−Client Protein Interactions
Rosser, M. F. N., Trotta, B. M., Marshall, M. R., Berwin, B. L., & Nicchitta, C. V. (2004) · Biochemistry · doi:10.1021/bi049539q · Cited by 45
Lang, A. E., Ernst, K., Lee, H., Papatheodorou, P., Schwan, C., Barth, H., & Aktories, K. (2013) · Cellular Microbiology · doi:10.1111/cmi.12228 · Cited by 44
Gupta, S. D., Revathi, B., Mazaira, G. I., Galigniana, M. D., Subrahmanyam, C. V. S., Gowrishankar, N. L., & Raghavendra, N. M. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.02.003 · Cited by 44
Induction of the Hypoxia-Inducible Factor System by Low Levels of Heat Shock Protein 90 Inhibitors
Ibrahim, N. O., Hahn, T., Franke, C., Stiehl, D. P., Wirthner, R., Wenger, R. H., & Katschinski, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1877 · Cited by 47
Saha, S. K., & Khuda‐Bukhsh, A. R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.009 · Cited by 47
Metadata
- Authors
- Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H.
- Affiliations
- University College London (GB)
- Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, U.K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-01-01
- Volume
- 42
- Issue
- 2
- Pages
- 260-266
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2042699875
- Cited by
- 1,004
- References
- 26
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 17 · 2022: 24 · 2021: 23 · 2020: 38 · 2019: 45 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 43 · 2014: 47 · 2013: 31 · 2012: 50
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- HSP90, molecular chaperones, geldanamycin, radicicol, antitumor antibiotics, ATPase inhibition, protein folding
- MeSH terms
- Adenosine Diphosphate, Adenosine Triphosphatases, Antibiotics, Antineoplastic, Calorimetry, Lactones, Models, Molecular, Quinones, Structure-Activity Relationship, Benzoquinones, Crystallography, X-Ray, Molecular Mimicry, HSP90 Heat-Shock Proteins, Macrolides, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.